CHEK1 and neoplasm: We therefore hypothesized that ecDNA-containing tumour cells, due to their intrinsic heightened RS, would be hyperreliant on CHK1 to manage DNA damage, and that CHK1 inhibition (CHK1i) could trigger preferential cell death in ecDNA-containing tumour cells.